How Inflammatory Bowel Diseases Medications Work

Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, are chronic conditions characterized by inflammation of the gastrointestinal tract. The primary goal of medication therapy is to reduce inflammation, induce remission, and maintain long-term control.

Gold Standard: Aminosalicylates

The gold standard for treating mild to moderate IBD is aminosalicylates, such as sulfasalazine. These medications work by:

• Inhibiting the production of inflammatory mediators, including prostaglandins and leukotrienes.
• Reducing inflammation in the gastrointestinal tract.

Alternatives: Immunomodulators, Biologics, and JAK Inhibitors

For moderate to severe IBD or when aminosalicylates are ineffective, alternative medications may be used. These include:

• Immunomodulators, such as azathioprine, which suppress the immune system and reduce inflammation.
• Biologics, like infliximab, which target specific proteins involved in inflammation, including tumor necrosis factor-alpha (TNF-α).
• JAK inhibitors, such as tofacitinib, which block the activity of Janus kinase enzymes, reducing inflammation and immune response.